Endocannabinoids: biology, mechanism of action and functions

[1] Howlett AC(2002)International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 161-202

[2] Barth F(1992)Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946-1949

[3] Bonner TI(1995)Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 83-90

[4] Cabral G(1995)2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 89-97

[5] Casellas P(2002)Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 1020-1024

[6] Devane WA(2004)The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 771-784

[7] Devane WA(2004)Endocannabinoid-mediated metaplasticity in the hippocampus Neuron 43 871-881

[8] Hanus L(2001)Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 822-825

[9] Breuer A(2003)The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J Clin Invest 112 423-431

[10] Pertwee RG(2004)CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity Int J Obes Relat Metab Disord 28 640-648

[1] Howlett AC(2002)International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 161-202

[2] Barth F(1992)Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946-1949

[3] Bonner TI(1995)Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 83-90

[4] Cabral G(1995)2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 89-97

[5] Casellas P(2002)Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 1020-1024

[6] Devane WA(2004)The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 771-784

[7] Devane WA(2004)Endocannabinoid-mediated metaplasticity in the hippocampus Neuron 43 871-881

[8] Hanus L(2001)Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 822-825

[9] Breuer A(2003)The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis J Clin Invest 112 423-431

[10] Pertwee RG(2004)CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity Int J Obes Relat Metab Disord 28 640-648